Arrhythmia Flashcards

1
Q

Reverse use dependence

A
Increased effect at slow heart rates 
All class III drugs including dofetilide 

III: block outward potassium channel activity (IKs) and prolong refractoriness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dofetilide side effects

A

Hypomagnesemia, hypokalemia, QT prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pacemaker cardiomyopathy

A

12% of patients who are paced >20% of the time-> change or upgrade to biventricular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ventricular pacing alone (without atrial pacing) increases

A

Afib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of LQTS

A
Genetic testing of index patient 
Beta blockers 
ICDs if strong personal risk factors for SCD 
QTC > 480ms more definitive 
Polymorphic VT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Persistent afib
Paroxysmal
Long-standing persistent
Permanent

A

> 7 days
<7 days
12 months
We have stopped attempts to control and accepted it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Primary prevention ICD (MADIT-II trial)

A

Just EF and GDMT?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CRT (biventricular ICD) indication

A

EF <35%, QRS> 150, LBBB, sinus rhythm, class II-IV despite GDMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Palpitations work up

24 hour holter vs event monitor

A

If risk factors for cardiac disease, attempt to correlate with monitor

Event monitor generally shown to be better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Palpitations and lightheaded ness with exercise and emotion in young person, positive family history

A

CPVT

Ryanodine receptor mutation more common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Transforming growth factor-beta (TGF-β) mutations

A

Familial thoracic aortic aneurysms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fibrillin mutation

A

Marfan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Myosin heavy chain mutation

A

HCOM and dilated cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Plakophilin mutation

A

ARVC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Monomorphiv VT that originates in RVOT

Differential

A

LBBB morphology (down in V1) with inferior axis, can ablate / BB/ CCB/ class 1C

idiopathic VT and arrhythmogenic right ventricular cardiomyopathy (ARVC)

RVOT VT is usually not ischemia driven

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ARVC

A

Epsilon wave after QRS and TWIs in V1-V3

Get CT/MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Arrhythmias in Brugada

A

Beta blockers CI- increase ST elevation
Amiodarone is pro arrhythmic

Treat fever, avoid drugs and alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Quinidine for

A

ICD w/ multiple shocks for VT

ICD is CI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

LVOT VT

A

LBBB, inferior axis, early R wave progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

VT in structurally normal heart

VT in abnormal heart

A

Meds or ablate

ICD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Most common cause of VT (wise complex, positive concordance, monophasic R in V1) in CAD

A

Scar-mediated, re-entrant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Torsades in LQTS mechanism

A

Early afterdepolarizations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mobitz type II vs complete heart block

A

Fixed PR interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Brugada

A

Sodium channel blockers (flecainide, propafenone) can exacerbate the transient ECG abnormalities that occur in patients with Brugada syndrome who commonly have normal ECGs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

AF with aberrancy, WPW

Do not give

A

Beta blocker, adenosine, dig.

Use ibitulide and procainamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

AF with WPW vs plain AF

A

Wide complex vs narrow complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

2:1 block, differentiate between Mobitz I and II

A

I may be due to increased vagal tone in athletes- improves with exercise

II is due to His disease- worsens with exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

atrial tachycardia, atrial flutter, or atrial fibrillation in adult congenital heart disease patients

A

progressive hemodynamic deterioration of the underlying disease
Obtain TTE and address arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Marked first degree AV block can cause fatigue

A

> 300, cannon a waves
Due to AV dyssynchrony- atrium contracts before complete filling-> decreased ventricular filling
May benefit from pacing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Cardio inhibitory syncope

A

Vagally mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Sotalol side effect

A

Non sustained torsades

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Sotalol

A

Class III
Blocks inward potassium channel, prolongs QT

Risk is higher in bradycardia, female sex, pre-existing QT prolongation, history of heart failure, history of ventricular tachycardia/ventricular fibrillation, or hypokalemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Sustained torsades treatment

A

If unstable- shock
If stable- IV mag

IV isoproterenol (increases HR, decreases QT) 
No beta blockers or amiodarone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Underlying causes of afib

A

hypertension, obstructive sleep apnea, and obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

AV block (complete heart block) vs AV dissociation (AIVR)

A

Atrial rate is faster

Ventricular rate is faster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Tachy Brady syndrome

A

Post AF conversion pause - sinus node dysfunction + afib

Avoid sodium channel blockers like flecainide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

ARVC lifestyle

A

high risk of ventricular arrhythmias and sudden death

avoid competitive sports and endurance training
Can do billiards, bowling, cricket, curling, golf, and riflery
Consider family screening, may need ICD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Polymorphic (multiple QRS morphology) tachy risk factors

Drugs

Ischemia is a common cause

A

baseline QT prolongation, bradycardia, and electrolyte disturbances (especially hypokalemia and hypomagnesemia, and less often hypocalcemia).

Levo and albuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Non–isthmus-dependent (atypical) atrial flutter mechanism

Underlying etiology

Treatment

A

macro–re-entrant circuits elsewhere in the RA or LA

congenital heart disease, after cardiac surgery, and after catheter ablation of AF.

Rate control-> EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Afib mechanism

AVNRT mechanism

A

Rapid focal ectopic activity (pulmonary veins)

Re-entry within triangle of Koch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Type 1 Brugada, sudden death in family member

A

ICD is not indicated

Indicated in personal history of cardiac arrest or syncope (at rest, not vasovagal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Typical atrial flutter vs atypical

A

Sawtooth in inferior leads, positive in V1: cavotricuspid, can be ablated

Fossa ovalis or SVC

43
Q

Acute renal failure, stop

A

Atenolol, accumulates

44
Q

ARVC VT

Idiopathic RVOT VT

A

Beta blocker -> ablation

Ablation

45
Q

Afib underlying causes

A

hyperthyroidism, pericarditis, pulmonary embolism, and electrolyte abnormalities (r/o)

46
Q

AVNRT

A

Most frequent SVT, Cannon a waves (neck discomfort)

AVRT
Atrial tachycardia

47
Q

Narrow complex regular tachycardia

A
SVT: 
AVNRT (dual pathway)
AVRT (accessory pathway) 
AT (ectopic Ps, organized atrial activity with adenosine)
Sinus tachycardia 
Junctional tachycardia
48
Q

Narrow complex irregularly irregular tachycardia

A

AF
MAT
Sinus arrhythmia

Any pattern= regularly irregular

49
Q

Flutter or fib for less than 48 hours

A

Can be DC cardioverted without TEE

  • Rate control is difficult in flutter, aim for rhythm control if possible* (cardioversion preferred)
50
Q

Brugada type 2 (saddle back)/ 3

A

ECG with superior placement of V1 and V2/ block sodium channels with flecainide to unmask

Provocative testing such as drug challenge with procainamide or flecainide or programmed electrical stimulation during electrophysiology testing

51
Q

Prolonged QT-> PMVT-> vfib mechanism

A

Early after depolarizations

Hydroxychloroquine

52
Q

PMVT due to acute ischemia mechanism

A

causes re-entry due to loss of the epicardial action-potential dome in phase II.

53
Q

Treatment of recurrent symptomatic SVT

A

Ablation

54
Q

Fever, alcohol and cocaine unmask Brugada

Gene mutation

A

SCN5A

55
Q

PVC ablation

Work up

A

> 25%

Holter monitor-> implantable loop recorder

56
Q

Inappropriate sinus tachy treatment

A

Ivabradine (if current in SA node, drives sinus rate)

Beta blockers not effective

57
Q

Sinus node dysfunction

A

persistent sinus bradycardia , chronotropic incompetence, paroxysmal or persistent sinus arrest with replacement by subsidiary escape rhythms in the atrium, atrioventricular (AV) junction, or ventricular myocardium

58
Q

Chronotropic incompetence

Deconditioning

A

peak heart rate <100 bpm and <70% age-predicted maximum heart rate.

Exaggerated HR response during exercise

59
Q

First degree vs Mobitz I vs Mobitz II

A

No dropped ps vs increased PR, narrow complex vs normal PR, sometimes wide qrs

60
Q

Mobitz I vs Mobitz II

A

AV nodal block vs His

Carotid sinus massage worsens AV block, improve His conduction

Exercise improves AV conduction, worsens His

61
Q

Flecainide/ propafenone

Sotalol

A

Class Ic, Na blocker
Dissociate slowly during diastole-> use dependence
Effective for pill in pocket SVT
can exacerbate underlying conduction system disease, unmasking sinus node dysfunction (post conversion pause), atrioventricular block, or infrahisian block, and increases in the P-R and QRS intervals of ≤25%

Class III, potassium channel blocker
Reverse use dependence, effective at slower heart rates, use daily

62
Q

Afib > 48 hours

Post cardioversion anticoagulation (there is risk with cardioversion)

A
Anticoagulate and TEE before cardioversion
4 weeks (Long term AC is determined by CV score)
63
Q

VT/ NSVT/ PVCs:
Negative in V1( left bundle morphology)
Positive in V1( right bundle morphology)

A

Differentiate normal heart from structural heart disease

RVOT (idiopathic vs ARVC) 
Left ventricle (different morphologies= cardiomyopathy) 

ICD if there is structural heart disease

64
Q

Bidirectional VT

A

Digoxin toxicity (dronaderone increases, so does amiodarone)

Amiodarone and warfarin also = drug interaction

65
Q

WPW EKG

EKG+ symptoms

If uninterested in ablation

A

Noninvasive exercise testing to risk stratify
Disappearance of delta wave = low risk
Persistent, gradual shortening= high risk

Straight to ablation, no need for stress test

If no SHD, beta blocker / CCB, flecainide or propafenone

66
Q

Afib+ asymptomatic, normal EF

Target HR

A

Rate control and AC
Can consider ablation if symptomatic or decreases EF

<110 (RACE-II)

67
Q

Rate control = rhythm control

Factors to consider

A

age (rate in older), symptoms (rhythm?), duration of AF (>48 hrs- rate) evidence of tachycardia-mediated cardiomyopathy (rhythm), or difficulty in achieving adequate rate control.???

68
Q

Permanent AF

Can prevent effective pacing

A

Can not restore sinus, so no need for antiarrhythmic drugs

Can ablate AV junction for rate control

69
Q

Pacing + LBBB

No response to CRT causes

A

RV pacing only

atrial fibrillation with rapid conduction, inappropriate device programming, and frequent ventricular ectopy, loss of LV lead capture or poor LV lead position

Response depends on >90% biv pacing

70
Q

CV risk of stroke

A

Corresponds till 4, then sequential increase 5_->7, 6-> 9, 7-> 10, 9-> 15

71
Q

SCD during swimming

LQTS syndrome treatment

A

Long QTS
Loss of function in potassium channel-> delay in membrane repolarization

Beta blocker -> ICD

72
Q

AF/flutter + HCOM

A

AC regardless of CV score

73
Q

1st / 2nd degree Brugada relative with normal ECG

A

Genetic testing

74
Q

PMVT-> acute ischemia

A

ongoing chest pain with a normal ECG canbe seen with an acute circumflex artery occlusio

75
Q

Monomorphic VT mechanism

A

Re-entry around a scar
Or
Single focus in structural heart disease

76
Q

BRUISE CONTROL

A

peridevice surgery anticoagulation

Warfarin better than lovenox

77
Q

Sinus node dysfunction types

A

symptomatic bradycardia, sinus pauses due to sinus arrest or sinoatrial exit block, and chronotropic incompetence.

78
Q

RVOT PVCs

A

LBBB with inferior axis and late R-wave progression, beyond V3
Ablate

79
Q

Irreversible symptomatic Brady due to SND or AV block (both types of second degree )

A

Pacemaker

80
Q

HCOM ICD

A

prior cardiac arrest/ sustained VT/ first degree SCD/ wall thickness >30 mm/ unexplained syncope

  • do not do dobutamine stress= increase LVOT gradient-dangerous*
81
Q

Unexplained syncope

A

Investigate with monitoring for arrhythmia and echo for LV dysfunction

82
Q

LQTS genetic testing

A

Strong clinical suspicion for LQTS and qt prolongation

Asymptomatic, idiopathic qtc >500/480 /460

83
Q

Prolonged qtc underlying causes

A

Bundle branch block, meds

84
Q

WPW treatment

A

Procainamide, ibutilide, cardioversion

No amiodarone or lidocaine

85
Q

Predicted max HR
Goal max HR
Chronotropic incompetence

A

220-Age
(220-Age)* 0.85
Inability to reach 80%

86
Q

Atrial tachycardia treatment

A

Ablate

If resistant, beta blockers, nondihydro

87
Q

MNVT mechanism

RVOT VT mechanism

Torsades mechanism

A

Scar mediated re-entry

Delayed and early afterdepolarization

Early afterdepolarization

88
Q

Timolol eye drops can cause

A

Brady arrhythmia in drug interactions with paroxetine for example

Rule out drugs before diagnosing SND

89
Q

VT
SHD
No SHD

A

ICD

Drugs or ablation

90
Q

Left ventricle fascicular VT

A

Re entrant tachy
Sensitive to verapamil
Can ablate

91
Q

Characteristic of wenckebach

A

Short PR after dropped P

92
Q

Hyperkalemia

A

Peaked T, wide QRS, prolonged PR

93
Q

Hypokalemia ECG

A

U wave

94
Q

bradycardia treatment

A
hemodynamically unstable, third-degree AV block with escape rates <40 bpm: transcutaneous pacing
Infra nodal (wide qrs, Mobitz II onwards): isoproterenol, will need pacemaker eventually
AV nodal (narrow qrs, first degree, Mobitz I): atropine
dopamine?
95
Q

advanced degree AV block

A

2 or more consecutive ps are blocked

96
Q

1 second on ecg strip

infranodal block

A

5 large boxes

wide qrs, mobitz II onwards (can be mobitz I)

97
Q

posterior fascicular VT

anterior fascicular VT

A

RBBB+ LAD

RBBB+ RAD

98
Q

2:1 block

A

Differentiate b/w Mobitz I vs II with carotid sinus massage or ETT

99
Q

Regularization of QRS in afib

A

Complete heart block

100
Q

Indeterminate axis differential

A

LAFB+ RVH

101
Q

Regularization of QRS in afib

A

Complete heart block

102
Q

Indeterminate axis differential

A

LAFB+ RVH

103
Q

Electrical storm treatment

A

Propanol